While RET fusions occur in 1-2% of NSCLC cases, there are at least 48 unique RET fusion partners identified in NSCLC, which have been catalogued by Ou and Zhou (34), with the most common being KIF5B-RET and CCDC6-RET. This evidence concerns the gene KIF5B and non-small cell lung carcinoma.